Crowdfunding

MED-X, INC.

Deadline passed 2025-05-27

Corporation · Nevada · Incorporated 2014-02-24

  • CIK 1620704
  • File 020-34208
  • State NV
Target Amount
$4,998
minimum to close
Maximum Amount
$4,999,998
ceiling, with over-subscription
Deadline
2025-05-27
as the latest Form C set it

Connected

named in its Form C filings

The intermediaries named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.

Latest Reported Offering

The terms on the latest Form C

Security Details

Type
Common Stock
Price per share
$3.00
Shares offered
1,666,666+

Offering Costs

Cash commission
—
The Company is offering securities under Regulation CF, through Intermediary. Intermediary will receive cash compensation equal to 8.5% of the value of the securities sold through Regulation CF, fixed fees of $32,500 and a monthly fee of $2,000.
Equity compensation
—
$0

Campaign timeline

target amount · by first filed
2024-05-28 · $4,998
  1. 2020-05-21$10,000020-26418
  2. 2023-01-19$10,000020-31642
  3. 2024-05-28$4,998020-34208

Hover a dot or row, or tab through the dots · bars scaled to the largest round ($10,000)

Reg D offerings

18 offerings

Private placements reported on Form D, separate from the crowdfunding raise: Reg CF sales are never counted in their sold amounts

Form D offerings
FileFirst filedLatestSoughtSoldInvestorsExemption
021-558910First filed2025-09-26Latest2025-09-26Sought$10.4MSold$0Investors0Exemption506(c)
021-548068First filed2025-06-04Latest2025-06-04Sought$3.5MSold$250KInvestors1Exemption506(c)
021-537978First filed2025-02-11Latest2025-02-12Sought$2.3MSold$428KInvestors6Exemption506(c)
021-525093First filed2024-09-26Latest2024-09-30Sought$2.3MSold$838KInvestors2Exemption506(b)
021-513840First filed2024-05-21Latest2024-05-21Sought$2.3MSold$250KInvestors2Exemption506(b)
021-506999First filed2024-03-07Latest2024-03-07Sought$1.2MSold$100KInvestors5Exemption506(c)
021-481898First filed2023-05-17Latest2023-05-17Sought$3.5MSold$120KInvestors5Exemption506(c)
021-464231First filed2022-11-08Latest2022-11-08Sought$3.5MSold$100KInvestors1Exemption506(c)
021-419265First filed2021-10-29Latest2021-10-29Sought$3.5MSold$1.2MInvestors4Exemption506(c)
021-397021First filed2021-04-23Latest2021-04-23Sought$3.5MSold$225KInvestors2Exemption506(c)
021-369458First filed2020-06-23Latest2020-06-23Sought$3MSold$600KInvestors3Exemption506(c)
021-346237First filed2019-08-09Latest2019-08-12Sought$3MSold$467KInvestors15Exemption506(c)
021-309340First filed2018-04-04Latest2018-04-04SoughtIndefiniteSold$0Investors433Exemption506(b)
021-305819First filed2018-02-16Latest2018-02-16Sought$3.5MSold$229KInvestors9Exemption506(c)
021-285979First filed2017-05-03Latest2017-05-03Sought$3.5MSold$12KInvestors1Exemption506(c)
021-273525First filed2016-10-31Latest2016-10-31Sought$1.4MSold$47KInvestors7Exemption506(c)
021-249849First filed2015-10-21Latest2015-10-21Sought$2.8MSold$55.5KInvestors5Exemption506(c)
021-225568First filed2014-10-01Latest2014-10-01Sought$5.5MSold$50KInvestors1Exemption506(c)
Its Form D page

Filing history

Form C family — 15 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
C-U020-34208DealMaker Securities LLC$5K target, up to $5M · Common Stock at $3.00 · closes 2025-05-27As of April 4, 2025, Med-X, Inc. (the "Company") has opted to terminate its Regulation CF Offering. The Company raised $1,678,671 with 1,218 investments.
C/A020-34208DealMaker Securities LLC$5K target, up to $5M · Common Stock at $3.00 · closes 2025-05-27Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000.
C/A020-34208DealMaker Securities LLC$5K target, up to $5M · Common Stock at $3.00 · closes 2024-09-30Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000.
C020-34208DealMaker Securities LLC$1.2M target · Common Stock at $3.00 · closes 2024-09-30—
C-W020-31642PicMii Crowdfunding——
C/A020-31642PicMii Crowdfunding$10K target, up to $3M · Common Stock at $0.25 · closes 2023-05-31Med-X, Inc. removed a reference to a potential public offering on their investment page. There is no public offering scheduled at this time and there may never be.
C020-31642PicMii Crowdfunding$10K target, up to $3M · Common Stock at $0.25 · closes 2023-05-31—
C-AR020-26418TrucrowdRevenue $1M · net income -$4.9M · 15 employees—
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2021-09-10Extending offering deadline.
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2021-05-31Extending offering deadline.
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2021-02-26Extending offering deadline.
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2020-11-30Extending offering deadline.
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2020-10-31Extending offering deadline.
C/A020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2020-08-31Extending offering deadline.
C020-26418Trucrowd$10K target, up to $1.1M · Common Stock at $0.80 · closes 2020-07-31—

Company Information

Legal Status
Corporation
Jurisdiction
Nevada
Date of Incorporation
2014-02-24

Latest Metrics

Most recent fiscal year, as the latest filing reports it

Employees
17
Total Assets
$1,345,328
Cash on Hand
$65,747
Revenues
$1,894,784
Net Income
$6,478,496

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist

Part of the Crowdfunding plan — $40/mo at launch pricing ($100 list)

See plans

View all SEC filings ↗